Phenominer Database Results (44 results)

 

How to display a graph
Strain Phenotype Conditions Study Experiment Name Sex Age # of Animals Formula Value Units SEM SD Method Method Duration Post Insult Time Value Method Notes Record ID Study ID
GK/MolTac hematocrit rosiglitazone (5 mg/kg) (for 23 days) then control condition (for 20 days) then fasting (for 12 hours) Gao W and Jusko WJ, J Pharmacol Exp Ther. 2012 Jun;341(3):617-25. doi: 10.1124/jpet.112.192419. Epub 2012 Feb 29. erythrocyte quantity male 122 days-129 days 5 53.4 % 1.25 2.8 automated hematology analysis 0.0 0 103870 2864
GK/MolTac hematocrit rosiglitazone (10 mg/kg) (for 23 days) then control condition (for 60 days) then fasting (for 12 hours) Gao W and Jusko WJ, J Pharmacol Exp Ther. 2012 Jun;341(3):617-25. doi: 10.1124/jpet.112.192419. Epub 2012 Feb 29. erythrocyte quantity male 164 days-171 days 7 57.7 % 0.23 0.6 automated hematology analysis 0.0 0 103874 2864
GK/MolTac blood hemoglobin A1c level rosiglitazone (10 mg/kg) (for 23 days) then fasting (for 12 hours) Gao W and Jusko WJ, J Pharmacol Exp Ther. 2012 Jun;341(3):617-25. doi: 10.1124/jpet.112.192419. Epub 2012 Feb 29. blood hemoglobin amount male 95 days-102 days 7 4.86 % 0.1 0.27 automated hematology analysis 0.0 0 103880 2864
GK/MolTac blood glucose level rosiglitazone (10 mg/kg) (for 23 days) then control condition (for 20 days) then fasting (for 16 hours) then glucose solution (2 g/kg) Gao W and Jusko WJ, J Pharmacol Exp Ther. 2012 Jun;341(3):617-25. doi: 10.1124/jpet.112.192419. Epub 2012 Feb 29. blood glucose amount male 122 days-129 days 4 145.0 mg/dl 7.5 15.0 oral glucose tolerance test 0.0 0 103810 2864
GK/MolTac whole body insulin sensitivity index rosiglitazone (5 mg/kg) (for 23 days) then fasting (for 12 hours) Gao W and Jusko WJ, J Pharmacol Exp Ther. 2012 Jun;341(3):617-25. doi: 10.1124/jpet.112.192419. Epub 2012 Feb 29. blood insulin amount male 95 days-102 days 3 10,000/√(FG x FI) x (Ḡ x Ī) 1.73 null 0.2 0.34 oral glucose tolerance test 7200.0 0 measured at -5,15,30,45,60,90,120 min 103827 2864
GK/MolTac whole body insulin sensitivity index rosiglitazone (10 mg/kg) (for 23 days) then control condition (for 20 days) then fasting (for 12 hours) Gao W and Jusko WJ, J Pharmacol Exp Ther. 2012 Jun;341(3):617-25. doi: 10.1124/jpet.112.192419. Epub 2012 Feb 29. blood insulin amount male 122 days-129 days 4 10,000/√(FG x FI) x (Ḡ x Ī) 2.04 null 0.21 0.42 oral glucose tolerance test 7200.0 0 measured at -5,15,30,45,60,90,120 min 103831 2864
GK/MolTac Homeostatic Model Assessment of Insulin Resistance rosiglitazone (5 mg/kg) (for 23 days) then control condition (for 20 days) then fasting (for 12 hours) Gao W and Jusko WJ, J Pharmacol Exp Ther. 2012 Jun;341(3):617-25. doi: 10.1124/jpet.112.192419. Epub 2012 Feb 29. blood insulin amount male 122 days-129 days 4 (fasting glucose x fasting insulin)/22.5 14.2 null 2.15 4.3 oral glucose tolerance test 7200.0 0 103837 2864
GK/MolTac blood hemoglobin level rosiglitazone (5 mg/kg) (for 23 days) then fasting (for 12 hours) Gao W and Jusko WJ, J Pharmacol Exp Ther. 2012 Jun;341(3):617-25. doi: 10.1124/jpet.112.192419. Epub 2012 Feb 29. blood hemoglobin amount male 95 days-102 days 6 16.6 g/dl 0.2 0.5 automated hematology analysis 0.0 0 103855 2864
GK/MolTac blood hemoglobin level rosiglitazone (10 mg/kg) (for 23 days) then control condition (for 60 days) then fasting (for 12 hours) Gao W and Jusko WJ, J Pharmacol Exp Ther. 2012 Jun;341(3):617-25. doi: 10.1124/jpet.112.192419. Epub 2012 Feb 29. blood hemoglobin amount male 164 days-171 days 7 17.8 g/dl 0.08 0.2 automated hematology analysis 0.0 0 103862 2864
GK/MolTac hematocrit rosiglitazone (5 mg/kg) (for 23 days) then control condition (for 60 days) then fasting (for 12 hours) Gao W and Jusko WJ, J Pharmacol Exp Ther. 2012 Jun;341(3):617-25. doi: 10.1124/jpet.112.192419. Epub 2012 Feb 29. erythrocyte quantity male 164 days-171 days 7 54.8 % 1.85 4.9 automated hematology analysis 0.0 0 103873 2864
GK/MolTac blood hemoglobin A1c level rosiglitazone (10 mg/kg) (for 23 days) then control condition (for 20 days) then fasting (for 12 hours) Gao W and Jusko WJ, J Pharmacol Exp Ther. 2012 Jun;341(3):617-25. doi: 10.1124/jpet.112.192419. Epub 2012 Feb 29. blood hemoglobin amount male 122 days-129 days 7 5.19 % 0.08 0.2 automated hematology analysis 0.0 0 103883 2864
GK/MolTac red blood cell count rosiglitazone (10 mg/kg) (for 23 days) then fasting (for 12 hours) Gao W and Jusko WJ, J Pharmacol Exp Ther. 2012 Jun;341(3):617-25. doi: 10.1124/jpet.112.192419. Epub 2012 Feb 29. erythrocyte quantity male 95 days-102 days 7 8.3 x 10E6 cells/ul 0.23 0.6 automated blood cell counting method 0.0 0 103844 2864
GK/MolTac blood insulin level AUC to blood glucose level AUC ratio rosiglitazone (10 mg/kg) (for 23 days) then fasting (for 12 hours) Gao W and Jusko WJ, J Pharmacol Exp Ther. 2012 Jun;341(3):617-25. doi: 10.1124/jpet.112.192419. Epub 2012 Feb 29. blood insulin amount male 95 days-102 days 4 AUC ins/glu 0.0 null 0.0 0.0 oral glucose tolerance test 7200.0 0 measured at -5,15,30,45,60,90,120 min 103821 2864
GK/MolTac blood insulin level AUC to blood glucose level AUC ratio rosiglitazone (5 mg/kg) (for 23 days) then control condition (for 20 days) then fasting (for 12 hours) Gao W and Jusko WJ, J Pharmacol Exp Ther. 2012 Jun;341(3):617-25. doi: 10.1124/jpet.112.192419. Epub 2012 Feb 29. blood insulin amount male 122 days-129 days 4 AUC ins/glu 0.0 null 0.0 0.0 oral glucose tolerance test 7200.0 0 measured at -5,15,30,45,60,90,120 min 103823 2864
GK/MolTac whole body insulin sensitivity index rosiglitazone (10 mg/kg) (for 23 days) then fasting (for 12 hours) Gao W and Jusko WJ, J Pharmacol Exp Ther. 2012 Jun;341(3):617-25. doi: 10.1124/jpet.112.192419. Epub 2012 Feb 29. blood insulin amount male 95 days-102 days 4 10,000/√(FG x FI) x (Ḡ x Ī) 1.72 null 0.3 0.59 oral glucose tolerance test 7200.0 0 measured at -5,15,30,45,60,90,120 min 103828 2864
GK/MolTac plasma insulin level rosiglitazone (5 mg/kg) (for 23 days) then fasting (for 12 hours) Gao W and Jusko WJ, J Pharmacol Exp Ther. 2012 Jun;341(3):617-25. doi: 10.1124/jpet.112.192419. Epub 2012 Feb 29. blood insulin amount male 95 days-102 days 3 30.42 mU/l 4.2 7.28 oral glucose tolerance test 0.0 0 103813 2864
GK/MolTac plasma insulin level rosiglitazone (10 mg/kg) (for 23 days) then fasting (for 12 hours) Gao W and Jusko WJ, J Pharmacol Exp Ther. 2012 Jun;341(3):617-25. doi: 10.1124/jpet.112.192419. Epub 2012 Feb 29. blood insulin amount male 95 days-102 days 4 34.58 mU/l 4.68 9.36 oral glucose tolerance test 0.0 0 103814 2864
GK/MolTac red blood cell count rosiglitazone (5 mg/kg) (for 23 days) then control condition (for 20 days) then fasting (for 12 hours) Gao W and Jusko WJ, J Pharmacol Exp Ther. 2012 Jun;341(3):617-25. doi: 10.1124/jpet.112.192419. Epub 2012 Feb 29. erythrocyte quantity male 122 days-129 days 5 9.0 x 10E6 cells/ul 0.22 0.5 automated blood cell counting method 0.0 0 103846 2864
GK/MolTac blood hemoglobin level rosiglitazone (5 mg/kg) (for 23 days) then control condition (for 60 days) then fasting (for 12 hours) Gao W and Jusko WJ, J Pharmacol Exp Ther. 2012 Jun;341(3):617-25. doi: 10.1124/jpet.112.192419. Epub 2012 Feb 29. blood hemoglobin amount male 164 days-171 days 5 16.7 g/dl 0.72 1.6 automated hematology analysis 0.0 0 103861 2864
GK/MolTac hematocrit rosiglitazone (10 mg/kg) (for 23 days) then control condition (for 20 days) then fasting (for 12 hours) Gao W and Jusko WJ, J Pharmacol Exp Ther. 2012 Jun;341(3):617-25. doi: 10.1124/jpet.112.192419. Epub 2012 Feb 29. erythrocyte quantity male 122 days-129 days 7 54.1 % 0.83 2.2 automated hematology analysis 0.0 0 103871 2864
GK/MolTac blood glucose level rosiglitazone (10 mg/kg) (for 23 days) then fasting (for 16 hours) then glucose solution (2 g/kg) Gao W and Jusko WJ, J Pharmacol Exp Ther. 2012 Jun;341(3):617-25. doi: 10.1124/jpet.112.192419. Epub 2012 Feb 29. blood glucose amount male 95 days-102 days 4 142.0 mg/dl 4.0 8.0 oral glucose tolerance test 0.0 0 103807 2864
GK/MolTac whole body insulin sensitivity index rosiglitazone (5 mg/kg) (for 23 days) then control condition (for 20 days) then fasting (for 12 hours) Gao W and Jusko WJ, J Pharmacol Exp Ther. 2012 Jun;341(3):617-25. doi: 10.1124/jpet.112.192419. Epub 2012 Feb 29. blood insulin amount male 122 days-129 days 4 10,000/√(FG x FI) x (Ḡ x Ī) 1.27 null 0.23 0.46 oral glucose tolerance test 7200.0 0 measured at -5,15,30,45,60,90,120 min 103830 2864
GK/MolTac Homeostatic Model Assessment of Insulin Resistance rosiglitazone (5 mg/kg) (for 23 days) then fasting (for 12 hours) Gao W and Jusko WJ, J Pharmacol Exp Ther. 2012 Jun;341(3):617-25. doi: 10.1124/jpet.112.192419. Epub 2012 Feb 29. blood insulin amount male 95 days-102 days 3 (fasting glucose x fasting insulin)/22.5 9.8 null 1.21 2.1 oral glucose tolerance test 7200.0 0 103834 2864
GK/MolTac Homeostatic Model Assessment of Insulin Resistance rosiglitazone (10 mg/kg) (for 23 days) then fasting (for 12 hours) Gao W and Jusko WJ, J Pharmacol Exp Ther. 2012 Jun;341(3):617-25. doi: 10.1124/jpet.112.192419. Epub 2012 Feb 29. blood insulin amount male 95 days-102 days 4 (fasting glucose x fasting insulin)/22.5 10.2 null 1.35 2.7 oral glucose tolerance test 7200.0 0 103835 2864
GK/MolTac plasma insulin level rosiglitazone (10 mg/kg) (for 23 days) then control condition (for 20 days) then fasting (for 12 hours) Gao W and Jusko WJ, J Pharmacol Exp Ther. 2012 Jun;341(3):617-25. doi: 10.1124/jpet.112.192419. Epub 2012 Feb 29. blood insulin amount male 122 days-129 days 4 27.3 mU/l 4.16 8.32 oral glucose tolerance test 0.0 0 103817 2864
GK/MolTac red blood cell count rosiglitazone (5 mg/kg) (for 23 days) then control condition (for 60 days) then fasting (for 12 hours) Gao W and Jusko WJ, J Pharmacol Exp Ther. 2012 Jun;341(3):617-25. doi: 10.1124/jpet.112.192419. Epub 2012 Feb 29. erythrocyte quantity male 164 days-171 days 5 9.3 x 10E6 cells/ul 0.36 0.8 automated blood cell counting method 0.0 0 103849 2864
GK/MolTac blood hemoglobin A1c level rosiglitazone (5 mg/kg) (for 23 days) then control condition (for 20 days) then fasting (for 12 hours) Gao W and Jusko WJ, J Pharmacol Exp Ther. 2012 Jun;341(3):617-25. doi: 10.1124/jpet.112.192419. Epub 2012 Feb 29. blood hemoglobin amount male 122 days-129 days 5 5.2 % 0.1 0.22 automated hematology analysis 0.0 0 103882 2864
GK/MolTac red blood cell count rosiglitazone (10 mg/kg) (for 23 days) then control condition (for 60 days) then fasting (for 12 hours) Gao W and Jusko WJ, J Pharmacol Exp Ther. 2012 Jun;341(3):617-25. doi: 10.1124/jpet.112.192419. Epub 2012 Feb 29. erythrocyte quantity male 164 days-171 days 7 9.8 x 10E6 cells/ul 0.04 0.1 automated blood cell counting method 0.0 0 103850 2864
GK/MolTac blood hemoglobin level rosiglitazone (10 mg/kg) (for 23 days) then control condition (for 20 days) then fasting (for 12 hours) Gao W and Jusko WJ, J Pharmacol Exp Ther. 2012 Jun;341(3):617-25. doi: 10.1124/jpet.112.192419. Epub 2012 Feb 29. blood hemoglobin amount male 122 days-129 days 7 17.0 g/dl 0.19 0.5 automated hematology analysis 0.0 0 103859 2864
GK/MolTac hematocrit rosiglitazone (5 mg/kg) (for 23 days) then fasting (for 12 hours) Gao W and Jusko WJ, J Pharmacol Exp Ther. 2012 Jun;341(3):617-25. doi: 10.1124/jpet.112.192419. Epub 2012 Feb 29. erythrocyte quantity male 95 days-102 days 6 53.8 % 0.65 1.6 automated hematology analysis 0.0 0 103867 2864
GK/MolTac red blood cell count rosiglitazone (10 mg/kg) (for 23 days) then control condition (for 20 days) then fasting (for 12 hours) Gao W and Jusko WJ, J Pharmacol Exp Ther. 2012 Jun;341(3):617-25. doi: 10.1124/jpet.112.192419. Epub 2012 Feb 29. erythrocyte quantity male 122 days-129 days 7 9.4 x 10E6 cells/ul 0.08 0.2 automated blood cell counting method 0.0 0 103847 2864
GK/MolTac red blood cell count rosiglitazone (5 mg/kg) (for 23 days) then fasting (for 12 hours) Gao W and Jusko WJ, J Pharmacol Exp Ther. 2012 Jun;341(3):617-25. doi: 10.1124/jpet.112.192419. Epub 2012 Feb 29. erythrocyte quantity male 95 days-102 days 6 8.9 x 10E6 cells/ul 0.08 0.2 automated blood cell counting method 0.0 0 103843 2864
GK/MolTac blood insulin level AUC to blood glucose level AUC ratio rosiglitazone (10 mg/kg) (for 23 days) then control condition (for 20 days) then fasting (for 12 hours) Gao W and Jusko WJ, J Pharmacol Exp Ther. 2012 Jun;341(3):617-25. doi: 10.1124/jpet.112.192419. Epub 2012 Feb 29. blood insulin amount male 122 days-129 days 4 AUC ins/glu 0.0 null 0.0 0.0 oral glucose tolerance test 7200.0 0 measured at -5,15,30,45,60,90,120 min 103824 2864
GK/MolTac Homeostatic Model Assessment of Insulin Resistance rosiglitazone (10 mg/kg) (for 23 days) then control condition (for 20 days) then fasting (for 12 hours) Gao W and Jusko WJ, J Pharmacol Exp Ther. 2012 Jun;341(3):617-25. doi: 10.1124/jpet.112.192419. Epub 2012 Feb 29. blood insulin amount male 122 days-129 days 4 (fasting glucose x fasting insulin)/22.5 8.2 null 1.35 2.7 oral glucose tolerance test 7200.0 0 103838 2864
GK/MolTac plasma insulin level rosiglitazone (5 mg/kg) (for 23 days) then control condition (for 20 days) then fasting (for 12 hours) Gao W and Jusko WJ, J Pharmacol Exp Ther. 2012 Jun;341(3):617-25. doi: 10.1124/jpet.112.192419. Epub 2012 Feb 29. blood insulin amount male 122 days-129 days 4 38.22 mU/l 5.2 10.4 oral glucose tolerance test 0.0 0 103816 2864
GK/MolTac blood glucose level rosiglitazone (5 mg/kg) (for 23 days) then fasting (for 16 hours) then glucose solution (2 g/kg) Gao W and Jusko WJ, J Pharmacol Exp Ther. 2012 Jun;341(3):617-25. doi: 10.1124/jpet.112.192419. Epub 2012 Feb 29. blood glucose amount male 95 days-102 days 3 146.0 mg/dl 3.46 6.0 oral glucose tolerance test 0.0 0 103806 2864
GK/MolTac blood hemoglobin level rosiglitazone (5 mg/kg) (for 23 days) then control condition (for 20 days) then fasting (for 12 hours) Gao W and Jusko WJ, J Pharmacol Exp Ther. 2012 Jun;341(3):617-25. doi: 10.1124/jpet.112.192419. Epub 2012 Feb 29. blood hemoglobin amount male 122 days-129 days 5 16.3 g/dl 0.54 1.2 automated hematology analysis 0.0 0 103858 2864
GK/MolTac hematocrit rosiglitazone (10 mg/kg) (for 23 days) then fasting (for 12 hours) Gao W and Jusko WJ, J Pharmacol Exp Ther. 2012 Jun;341(3):617-25. doi: 10.1124/jpet.112.192419. Epub 2012 Feb 29. erythrocyte quantity male 95 days-102 days 7 49.8 % 1.4 3.7 automated hematology analysis 0.0 0 103868 2864
GK/MolTac blood hemoglobin A1c level rosiglitazone (5 mg/kg) (for 23 days) then fasting (for 12 hours) Gao W and Jusko WJ, J Pharmacol Exp Ther. 2012 Jun;341(3):617-25. doi: 10.1124/jpet.112.192419. Epub 2012 Feb 29. blood hemoglobin amount male 95 days-102 days 6 4.95 % 0.06 0.15 automated hematology analysis 0.0 0 103879 2864
GK/MolTac blood hemoglobin A1c level rosiglitazone (5 mg/kg) (for 23 days) then control condition (for 60 days) then fasting (for 12 hours) Gao W and Jusko WJ, J Pharmacol Exp Ther. 2012 Jun;341(3):617-25. doi: 10.1124/jpet.112.192419. Epub 2012 Feb 29. blood hemoglobin amount male 164 days-171 days 7 5.86 % 0.24 0.64 automated hematology analysis 0.0 0 103885 2864
GK/MolTac blood hemoglobin A1c level rosiglitazone (10 mg/kg) (for 23 days) then control condition (for 60 days) then fasting (for 12 hours) Gao W and Jusko WJ, J Pharmacol Exp Ther. 2012 Jun;341(3):617-25. doi: 10.1124/jpet.112.192419. Epub 2012 Feb 29. blood hemoglobin amount male 164 days-171 days 7 5.61 % 0.12 0.32 automated hematology analysis 0.0 0 103886 2864
GK/MolTac blood glucose level rosiglitazone (5 mg/kg) (for 23 days) then control condition (for 20 days) then fasting (for 16 hours) then glucose solution (2 g/kg) Gao W and Jusko WJ, J Pharmacol Exp Ther. 2012 Jun;341(3):617-25. doi: 10.1124/jpet.112.192419. Epub 2012 Feb 29. blood glucose amount male 122 days-129 days 4 177.0 mg/dl 5.5 11.0 oral glucose tolerance test 0.0 0 103809 2864
GK/MolTac blood insulin level AUC to blood glucose level AUC ratio rosiglitazone (5 mg/kg) (for 23 days) then fasting (for 12 hours) Gao W and Jusko WJ, J Pharmacol Exp Ther. 2012 Jun;341(3):617-25. doi: 10.1124/jpet.112.192419. Epub 2012 Feb 29. blood insulin amount male 95 days-102 days 3 AUC ins/glu 0.0 null 0.0 0.0 oral glucose tolerance test 7200.0 0 measured at -5,15,30,45,60,90,120 min 103820 2864
GK/MolTac blood hemoglobin level rosiglitazone (10 mg/kg) (for 23 days) then fasting (for 12 hours) Gao W and Jusko WJ, J Pharmacol Exp Ther. 2012 Jun;341(3):617-25. doi: 10.1124/jpet.112.192419. Epub 2012 Feb 29. blood hemoglobin amount male 95 days-102 days 7 15.4 g/dl 0.45 1.2 automated hematology analysis 0.0 0 103856 2864